Literature DB >> 11123078

Long-term cardiac sequelae of Kawasaki disease.

D R Fulton1, J W Newburger.   

Abstract

Kawasaki disease is the leading cause of acquired heart disease in childhood. Despite treatment with intravenous gamma globulin, 2% to 4% of patients have coronary abnormalities. Those with giant aneurysms are at risk for stenosis and myocardial ischemia/infarction, and require aggressive anticoagulation with frequent follow-up, including stress testing and coronary angiography. In rare cases, patients will have coronary artery bypass grafting. Those with less severe coronary involvement need antiplatelet therapy and infrequent noninvasive testing. Patients with normal echos after the acute phase are not treated, but the future impact of the disease is not certain particularly in the setting of adult onset coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123078     DOI: 10.1007/s11926-000-0070-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  39 in total

1.  Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography.

Authors:  O Muzik; S M Paridon; T P Singh; W R Morrow; F Dayanikli; M F Di Carli
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

2.  Intracoronary streptokinase in Kawasaki disease: acute and late thrombolysis.

Authors:  J P Cheatham; J D Kugler; C H Gumbiner; L A Latson; P J Hofschire
Journal:  Prog Clin Biol Res       Date:  1987

3.  Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease.

Authors:  T M Anderson; R A Meyer; S Kaplan
Journal:  Am Heart J       Date:  1985-07       Impact factor: 4.749

4.  Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing.

Authors:  T Fukuda; T Akagi; M Ishibashi; O Inoue; T Sugimura; H Kato
Journal:  Am Heart J       Date:  1998-03       Impact factor: 4.749

5.  Feasibility of exercise stress echocardiography for the follow-up of children with coronary involvement secondary to Kawasaki disease.

Authors:  E Pahl; R Sehgal; D Chrystof; W H Neches; C L Webb; C E Duffy; S T Shulman; F A Chaudhry
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

6.  Tc-99m HMPAO WBC imaging to detect carditis and to evaluate the results of high-dose gamma globulin treatment in Kawasaki disease.

Authors:  C H Kao; K S Hsieh; Y L Wang; C W Chen; S Q Liao; S J Wang; S H Yeh
Journal:  Clin Nucl Med       Date:  1992-08       Impact factor: 7.794

7.  Tissue plasminogen activator for the treatment of thromboembolism in infants and children.

Authors:  M Levy; L N Benson; P E Burrows; Y Bentur; D K Strong; J Smith; D Johnson; S Jacobson; G Koren
Journal:  J Pediatr       Date:  1991-03       Impact factor: 4.406

8.  Cardiac and coronary arterial involvement in infants and children from New England with mucocutaneous lymph node syndrome (Kawasaki disease). Angiocardiographic-echocardiographic correlations.

Authors:  K J Chung; L Brandt; D R Fulton; M B Kreidberg
Journal:  Am J Cardiol       Date:  1982-07       Impact factor: 2.778

9.  Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases.

Authors:  A Suzuki; T Kamiya; N Kuwahara; Y Ono; T Kohata; O Takahashi; K Kimura; M Takamiya
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

10.  Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease.

Authors:  N Noto; M Ayusawa; K Karasawa; H Yamaguchi; N Sumitomo; T Okada; K Harada
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

View more
  6 in total

Review 1.  Update on the treatment of Kawasaki disease in childhood.

Authors:  Robert P Sundel
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

2.  Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.

Authors:  Chao Duan; Zhong-Dong Du; Yu Wang; Li-Qun Jia
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

3.  The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976.

Authors:  Ariane McNeal-Davidson; Anne Fournier; Rosie Scuccimarri; Adrian Dancea; Christine Houde; Marc Bellavance; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2012-06-17       Impact factor: 1.655

4.  Coronary insufficiency in children: Review of literature and report of a rare case with unknown aetiology.

Authors:  Ahmed A Arifi; Munir Ahmad; Ahmed Al Assal; Imad Naja; Hani K Najm
Journal:  J Saudi Heart Assoc       Date:  2010-02-24

5.  Interleukin-6 (-636 c/g) gene polymorphism in korean children with kawasaki disease.

Authors:  Hye Mi Ahn; In Sook Park; Soo-Jong Hong; Young Mi Hong
Journal:  Korean Circ J       Date:  2011-06-30       Impact factor: 3.243

6.  Mycoplasma pneumoniae infection in patients with Kawasaki disease.

Authors:  Mi Na Lee; Jie Hae Cha; Hye Mi Ahn; Jeong Hyun Yoo; Hae Soon Kim; Sejung Sohn; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2011-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.